Ashley is a Research Head of the Pattern Recognition Receptors and Inflammation research group within the Hudson’s Centre for Innate Immunity and Infectious Disease. From 2020-2023 he also held the position of Head of Translational Science at Adiso Therapeutics (Boston, USA), a start-up biopharmaceutical company creating novel therapies for inflammatory disease.